TMED3 and malignant colon neoplasm: A previous unbiased in vivo RNAi screen revealed TMED3 as a positive modulator of WNT signaling [8] and blocking WNT-TCF signaling with dnTCF has been shown to promote metastases from multiple primary colon cancer cells [6, 7].